Similar articles for PMID: 27354585

Year	Number of Results
2000	1
2001	1
2002	2
2003	2
2006	3
2007	4
2008	2
2009	7
2010	2
2012	7
2013	5
2014	7
2015	13
2016	15
2017	9
2018	1
2019	4
2020	1
2021	3
2022	1

1

Histone Methylation by Temozolomide; A Classic DNA Methylating Anticancer Drug.

Wang T, Pickard AJ, Gallo JM. Wang T, et al. Anticancer Res. 2016 Jul;36(7):3289-99. Anticancer Res. 2016. PMID: 27354585 Free PMC article.

2

A New Epigenetic Mechanism of Temozolomide Action in Glioma Cells.

Barciszewska AM, Gurda D, Głodowicz P, Nowak S, Naskręt-Barciszewska MZ. Barciszewska AM, et al. PLoS One. 2015 Aug 26;10(8):e0136669. doi: 10.1371/journal.pone.0136669. eCollection 2015. PLoS One. 2015. PMID: 26309255 Free PMC article.

3

Temozolomide and carmustine cause large-scale heterochromatin reorganization in glioma cells.

Papait R, Magrassi L, Rigamonti D, Cattaneo E. Papait R, et al. Biochem Biophys Res Commun. 2009 Feb 6;379(2):434-9. doi: 10.1016/j.bbrc.2008.12.091. Epub 2008 Dec 29. Biochem Biophys Res Commun. 2009. PMID: 19116135

4

Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.

Kohsaka S, Takahashi K, Wang L, Tanino M, Kimura T, Nishihara H, Tanaka S. Kohsaka S, et al. Cancer Lett. 2013 Apr 30;331(1):68-75. doi: 10.1016/j.canlet.2012.12.005. Epub 2012 Dec 12. Cancer Lett. 2013. PMID: 23246370

5

Temozolomide: mechanisms of action, repair and resistance.

Zhang J, Stevens MF, Bradshaw TD. Zhang J, et al. Curr Mol Pharmacol. 2012 Jan;5(1):102-14. doi: 10.2174/1874467211205010102. Curr Mol Pharmacol. 2012. PMID: 22122467

6

Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway.

Huang H, Lin H, Zhang X, Li J. Huang H, et al. Oncol Rep. 2012 Jun;27(6):2050-6. doi: 10.3892/or.2012.1715. Epub 2012 Mar 12. Oncol Rep. 2012. PMID: 22426504

7

MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.

Tian T, Mingyi M, Qiu X, Qiu Y. Tian T, et al. Oncotarget. 2016 Nov 29;7(48):79584-79595. doi: 10.18632/oncotarget.12861. Oncotarget. 2016. PMID: 27792996 Free PMC article.

8

Temozolomide-mediated DNA methylation in human myeloid precursor cells: differential involvement of intrinsic and extrinsic apoptotic pathways.

Wang H, Cai S, Ernstberger A, Bailey BJ, Wang MZ, Cai W, Goebel WS, Czader MB, Crean C, Suvannasankha A, Shokolenkoc I, Wilson GL, Baluyut AR, Mayo LD, Pollok KE. Wang H, et al. Clin Cancer Res. 2013 May 15;19(10):2699-709. doi: 10.1158/1078-0432.CCR-12-2671. Epub 2013 Mar 27. Clin Cancer Res. 2013. PMID: 23536437 Free PMC article.

9

Gene expression profiling predicts response to temozolomide in malignant gliomas.

Yoshino A, Ogino A, Yachi K, Ohta T, Fukushima T, Watanabe T, Katayama Y, Okamoto Y, Naruse N, Sano E, Tsumoto K. Yoshino A, et al. Int J Oncol. 2010 Jun;36(6):1367-77. doi: 10.3892/ijo_00000621. Int J Oncol. 2010. PMID: 20428759

10

Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts.

Kitange GJ, Carlson BL, Schroeder MA, Grogan PT, Lamont JD, Decker PA, Wu W, James CD, Sarkaria JN. Kitange GJ, et al. Neuro Oncol. 2009 Jun;11(3):281-91. doi: 10.1215/15228517-2008-090. Epub 2008 Oct 24. Neuro Oncol. 2009. PMID: 18952979 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed